
GC25168
Brepocitinib
Also listed as Brepocitinib (PF-06700841)
Brepocitinib (PF-06700841, PF-841) is a potent inhibitor of Tyk2 and Jak1 with IC50s of 23 nM, 17 nM, 77 nM for Tyk2, Jak1 and Jak2 respectively· It has appropriate in-family selectivity against JAK2 and JAK3
ChemicalCAS1883299-62-4MW389.4FormulaC18H21F2N7O
- CAS number
- 1883299-62-4
- Molecular weight
- 389.4
- Formula
- C18H21F2N7O
- Solubility
- DMSO: 78 mg/mL (200·31 mM);Water: Insoluble;Ethanol: 78 mg/mL (200·31 mM)
- InChIKey
- BUWBRTXGQRBBHG-MJBXVCDLSA-N
- Catalogue number
- GC25168
- Brand
- GLPBIO
Computed properties PubChem CID 118878093 · XLogP 1.5 · TPSA 79.2 Ų · H-bond donors 1
- XLogP
- 1.5
- TPSA
- 79.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 4
- Heavy atoms
- 28
SMILES CN1C=C(C=N1)NC2=NC=CC(=N2)N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]5CC5(F)F
Computed descriptors from PubChem (CID 118878093), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il